{
    "organizations": [],
    "uuid": "7a49252b4f01db363197c635955a1821bc2d534a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pfizer-and-allogene-enter-into-agr/brief-pfizer-and-allogene-enter-into-agreement-for-pfizers-car-t-cell-therapy-idUSB8N1RG000",
    "ord_in_thread": 0,
    "title": "BRIEF-Pfizer and Allogene enter into agreement for Pfizer's CAR T cell therapy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Pfizer Inc:\n* SAYS CO AND ALLOGENE THERAPEUTICS ENTER INTO ASSET CONTRIBUTION AGREEMENT FOR PFIZER’S ALLOGENEIC CAR T IMMUNO-­ONCOLOGY PORTFOLIO\n* SAYS AGREEMENT AIMS TO ACCELERATE THE DEVELOPMENT OF PFIZER’S CAR T CELL THERAPY\n* SAYS ALLOGENE WILL RECEIVE RIGHTS FROM CO TO 16 PRE-CLINICAL CAR T ASSETS LICENSED FROM CELLECTIS AND SERVIER\n* SAYS ALLOGENE WILL RECEIVE RIGHTS TO ONE CLINICAL ASSET FROM SERVIER CALLED UCART19\n* SAYS CO WILL HOLD 25 PERCENT STAKE IN ALLOGENE THERAPEUTICS; CO WILL BE REPRESENTED ON ALLOGENE’S BOARD Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-03T21:11:00.000+03:00",
    "crawled": "2018-04-04T12:40:57.022+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "pfizer",
        "inc",
        "say",
        "co",
        "allogene",
        "therapeutic",
        "enter",
        "asset",
        "contribution",
        "agreement",
        "pfizer",
        "allogeneic",
        "car",
        "portfolio",
        "say",
        "agreement",
        "aim",
        "accelerate",
        "development",
        "pfizer",
        "car",
        "cell",
        "therapy",
        "say",
        "allogene",
        "receive",
        "right",
        "co",
        "car",
        "asset",
        "licensed",
        "cellectis",
        "servier",
        "say",
        "allogene",
        "receive",
        "right",
        "one",
        "clinical",
        "asset",
        "servier",
        "called",
        "ucart19",
        "say",
        "co",
        "hold",
        "percent",
        "stake",
        "allogene",
        "therapeutic",
        "co",
        "represented",
        "allogene",
        "board",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}